J Cancer 2018; 9(16):2876-2884. doi:10.7150/jca.25351 This issue Cite

Research Paper

Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis

Can Yao1#, Hai-Ning Liu1#, Hao Wu1, Yan-Jie Chen1, Yu Li1, Ying Fang1, Xi-Zhong Shen1,2, Tao-Tao Liu1✉

1. Department of Gastroenterology, Zhongshan Hospital of Fudan University, 180 Fenglin Road, Shanghai 200032, China
2. Shanghai Institute of Liver Diseases, Zhongshan Hospital of Fudan University, 180 Fenglin Road, Shanghai 200032, China
# Contributed equally.

Citation:
Yao C, Liu HN, Wu H, Chen YJ, Li Y, Fang Y, Shen XZ, Liu TT. Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis. J Cancer 2018; 9(16):2876-2884. doi:10.7150/jca.25351. https://www.jcancer.org/v09p2876.htm
Other styles

File import instruction

Abstract

Background and Aim: MicroRNAs, dysregulated in the circulation of esophageal squamous cell carcinoma (ESCC) patient, have been assumed to be with great potential in the diagnosis and prognosis of esophageal cancer. We aimed to review previous articles on ESCC.

Methods: A search of electronic databases was performed before Nov 12, 2017. We summarized the identification of microRNA imbalance in the blood of ESCC compared with the healthy controls, with the objective to evaluate the efficiency of microRNAs in diagnosing and forecasting ESCC.

Results: A total of 35 studies investigating plasma or serum microRNAs were included in the meta-analysis. Based on the consequences of the quality assessment of each study, the articles involved were appropriate for quantitative synthesis. For diagnostic meta-analysis. The overall pooled sensitivity, specificity, and area under the curve of circulating microRNA is 0.794 (95% CI: 0.765 - 0.820), 0.779 (95%CI: 0.746 - 0.808), 0.86 (95%CI: 0.82 - 0.88). The diagnostic value of each microRNA was calculated respectively. For prognostic meta-analysis, the overall pooled hazard ratios of higher microRNA expression in circulation was 1.34 (95% CI: 1.14-1.58), which could significantly predict poorer survival in ESCC.

Conclusions: Circulating microRNAs distinguish patients with ESCC from healthy controls with high sensitivity and specificity, compared to other invasive currently used screening methods. Simultaneously, there was prognostic value for the prognosis of ESCC.

Keywords: Esophageal neoplasms, microRNA, diagnosis, prognosis, systematic review, meta-analysis


Citation styles

APA
Yao, C., Liu, H.N., Wu, H., Chen, Y.J., Li, Y., Fang, Y., Shen, X.Z., Liu, T.T. (2018). Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis. Journal of Cancer, 9(16), 2876-2884. https://doi.org/10.7150/jca.25351.

ACS
Yao, C.; Liu, H.N.; Wu, H.; Chen, Y.J.; Li, Y.; Fang, Y.; Shen, X.Z.; Liu, T.T. Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis. J. Cancer 2018, 9 (16), 2876-2884. DOI: 10.7150/jca.25351.

NLM
Yao C, Liu HN, Wu H, Chen YJ, Li Y, Fang Y, Shen XZ, Liu TT. Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis. J Cancer 2018; 9(16):2876-2884. doi:10.7150/jca.25351. https://www.jcancer.org/v09p2876.htm

CSE
Yao C, Liu HN, Wu H, Chen YJ, Li Y, Fang Y, Shen XZ, Liu TT. 2018. Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis. J Cancer. 9(16):2876-2884.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image